Northwestern Mutual Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.9M Buy
410,156
+166,559
+68% +$9.71M 0.02% 394
2025
Q4
$13.1M Buy
243,597
+23,136
+10% +$1.11M 0.01% 509
2025
Q3
$9.94M Buy
220,461
+7,440
+3% +$347K 0.01% 543
2025
Q2
$9.86M Buy
213,021
+18,093
+9% +$888K 0.01% 509
2025
Q1
$11.9M Sell
194,928
-1,795
-0.9% -$105K 0.01% 447
2024
Q4
$11.1M Buy
196,723
+13,951
+8% +$779K 0.01% 449
2024
Q3
$9.46M Buy
182,772
+2,932
+2% +$138K 0.01% 465
2024
Q2
$7.47M Sell
179,840
-10,894
-6% -$487K 0.01% 491
2024
Q1
$10.3M Sell
190,734
-6,083
-3% -$310K 0.01% 414
2023
Q4
$10.1M Sell
196,817
-23,069
-10% -$1.21M 0.01% 401
2023
Q3
$12.8M Buy
219,886
+9,568
+5% +$586K 0.02% 333
2023
Q2
$13.4M Buy
210,318
+1,576
+0.8% +$106K 0.02% 317
2023
Q1
$14.5M Sell
208,742
-3,109
-1% -$219K 0.02% 295
2022
Q4
$15.2M Buy
211,851
+3,631
+2% +$274K 0.02% 274
2022
Q3
$14.8M Sell
208,220
-5,790
-3% -$420K 0.03% 249
2022
Q2
$16.5M Sell
214,010
-828
-0.4% -$63.1K 0.03% 238
2022
Q1
$15.7M Sell
214,838
-23,923
-10% -$1.61M 0.03% 248
2021
Q4
$14.9M Buy
238,761
+5,773
+2% +$339K 0.02% 237
2021
Q3
$13.8M Buy
232,988
+4,182
+2% +$275K 0.03% 232
2021
Q2
$15.3M Buy
228,806
+10,823
+5% +$706K 0.03% 215
2021
Q1
$13.8M Buy
217,983
+10,573
+5% +$658K 0.03% 208
2020
Q4
$12.9M Sell
207,410
-79
-0% -$4.86K 0.03% 203
2020
Q3
$12.5M Sell
207,489
-3,091
-1% -$186K 0.03% 191
2020
Q2
$12.4M Buy
210,580
+17,619
+9% +$1.05M 0.04% 180
2020
Q1
$10.8M Buy
192,961
+3,018
+2% +$184K 0.04% 175
2019
Q4
$12.2M Buy
189,943
+44,213
+30% +$2.53M 0.04% 171
2019
Q3
$7.39M Buy
145,730
+3,206
+2% +$151K 0.03% 220
2019
Q2
$6.46M Sell
142,524
-8,288
-5% -$386K 0.03% 224
2019
Q1
$7.2M Buy
150,812
+8,762
+6% +$436K 0.03% 211
2018
Q4
$7.38M Buy
142,050
+10,885
+8% +$585K 0.04% 197
2018
Q3
$8.14M Buy
131,165
+7,747
+6% +$460K 0.04% 186
2018
Q2
$6.83M Buy
123,418
+2,323
+2% +$125K 0.04% 193
2018
Q1
$7.66M Buy
121,095
+15,576
+15% +$1M 0.05% 182
2017
Q4
$6.47M Buy
105,519
+818
+0.8% +$51.2K 0.04% 185
2017
Q3
$6.67M Buy
104,701
+6,496
+7% +$379K 0.05% 178
2017
Q2
$5.47M Buy
98,205
+323
+0.3% +$17.6K 0.04% 184
2017
Q1
$5.32M Buy
97,882
+5,851
+6% +$321K 0.05% 175
2016
Q4
$5.38M Buy
92,031
+84,268
+1,086% +$4.61M 0.06% 170
2016
Q3
$419K Sell
7,763
-75,448
-91% -$4.85M 0.03% 143
2016
Q2
$6.12M Buy
83,211
+5,731
+7% +$405K 0.09% 148
2016
Q1
$4.95M Buy
77,480
+3,196
+4% +$202K 0.08% 156
2015
Q4
$5.11M Buy
74,284
+1,859
+3% +$123K 0.1% 150
2015
Q3
$4.29M Buy
72,425
+13,817
+24% +$877K 0.1% 154
2015
Q2
$3.9M Sell
58,608
-203
-0.3% -$13.4K 0.1% 151
2015
Q1
$3.79M Buy
58,811
+2,237
+4% +$140K 0.11% 153
2014
Q4
$3.34M Buy
56,574
+2,002
+4% +$113K 0.1% 153
2014
Q3
$2.79M Buy
54,572
+1,677
+3% +$83.8K 0.1% 155
2014
Q2
$2.57M Buy
52,895
+744
+1% +$36.7K 0.1% 148
2014
Q1
$2.71M Sell
52,151
-1,149
-2% -$61.1K 0.11% 141
2013
Q4
$2.83M Buy
53,300
+740
+1% +$37.7K 0.13% 130
2013
Q3
$2.43M Buy
52,560
+4,914
+10% +$216K 0.13% 131
2013
Q2
$2.13M Buy
+47,646
New +$2.07M 0.13% 132

Other funds holding BMY

Northwestern Mutual Wealth Management's BMY Position: Q1 2026 in Review

Northwestern Mutual Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 68% in Q1 2026, buying an estimated $9.71M and bringing the position to 410,156 shares worth $24.9M. The position accounts for 0.02% of the portfolio, ranked #394.

Northwestern Mutual Wealth Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Northwestern Mutual Wealth Management held 410,156 shares of Bristol-Myers Squibb worth $24.9M as of Q1 2026.
  • Northwestern Mutual Wealth Management bought 166,559 Bristol-Myers Squibb shares in Q1 2026, an estimated $9.71M.
  • Bristol-Myers Squibb made up 0.02% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #394 holding.
  • Northwestern Mutual Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.